APA (7th ed.) Citation

Kumar, S. K., Buadi, F. K., LaPlant, B., Halvorson, A., Leung, N., Kapoor, P., . . . Lacy, M. Q. (2018). Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma. Blood Cancer Journal, 8(8), . https://doi.org/10.1038/s41408-018-0106-3

Chicago Style (17th ed.) Citation

Kumar, Shaji K., et al. "Phase 1/2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone in Patients with Previously Untreated Symptomatic Multiple Myeloma." Blood Cancer Journal 8, no. 8 (2018). https://doi.org/10.1038/s41408-018-0106-3.

MLA (9th ed.) Citation

Kumar, Shaji K., et al. "Phase 1/2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone in Patients with Previously Untreated Symptomatic Multiple Myeloma." Blood Cancer Journal, vol. 8, no. 8, 2018, https://doi.org/10.1038/s41408-018-0106-3.